Huntsman Corporation (HUN): what the price assumes

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/HUN

Headline

Field	Value
Ticker	HUN
Company	Huntsman Corporation
Sector / Industry	Basic Materials
Current price	$11.69/sh
Composition	Diversified 83% / Specialty 17% / Other 1% / Eliminations -1%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin (value-band context)	3.2%
Operating margin (mid-cycle)	6.2%
Margin compression (value-band)	-3.0pp
Trailing margin (depressed year)	-3.3%
Implied growth	-0.5%
Multiple paid	11x mid-cycle operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.6% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5.2pp.

How unusual the bet is: within-range (limited comparison data)

Reference	Value
vs own history	+0.13σ
implied end-window share	0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple value, while earnings-power/growth-DCF land below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	0.80x	2	justifies
Earnings	2.62x	1	expensive
Relative	0.24x	2	justifies
Growth	1.89x	3	expensive

Families that justify the price: Asset, Relative Families that call it expensive: Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.1%); the inversion above states its own rate.

Per-Model Detail (n=8)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$0.00	—	no	FCF base $0.1B, growth -5% (input: historical growth), terminal g 0.5%, WACC 6.1%, 5yr projection
DCF Exit Multiple	Growth	$9.59	1.22x	yes	Exit EV/EBITDA: 42.3x / 44.3x / 46.3x (bear / base = today's held flat / bull), 5yr
Relative Valuation	Relative	$49.36	0.24x	yes	P/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus
Simple DDM	Growth	$1.50	7.79x	yes	DPS $0.37, g=-12.4% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDM	Growth	$-4.57	—	no	Stage 1: -200% for 5yr, Stage 2: 3.5% perpetual
Simple Excess Return	Asset	$15.50	0.75x	yes	Reference only (book value floor): BV/sh $15.50, ROE negative
Two-Stage Excess Return	Asset	$13.95	0.84x	yes	Reference only (book value with convergence): BV/sh $15.50, ROE converges to ke
Discounted Future Market Cap	Growth	$6.20	1.89x	yes	Rev $5.7B, growth -5% (input: historical growth; tapered), Terminal P/S: 0.3x / 0.4x / 0.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair Value	Relative	$0.00	—	no	Negative/zero EPS — earnings-based value floored at $0
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$4.46	2.62x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $0.26B × (1−21%) / WACC 6.1% → EPV (no growth)
Residual Income	Asset	—	—	no	—
Graham Number	Asset	—	—	no	—
EV/EBITDA Relative	Relative	$0.01	1169.00x	yes	EBITDA $0.10B × sector EV/EBITDA 8.0x (excluded from median)
FCF Yield	Earnings	$0.01	1169.00x	yes	FCF $135.0M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF Yield	Earnings	$0.01	1169.00x	yes	SBC-adj FCF $0.10B (FCF $0.14B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham Formula	Earnings	—	—	no	—
ROIC-Justified P/B	Asset	—	—	no	—
P/Sales Sector	Relative	$49.36	0.24x	yes	Revenue $5.69B × sector P/S 1.5x
PEG Fair Value	Relative	—	—	no	—
Earnings Yield	Earnings	—	—	no	—
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$1.7b
Net debt / NOPAT (after-tax)	6.07x
Net debt / operating income (pre-tax)	4.79x
Share count CAGR (buyback)	-5.3%
Burning cash	no

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 6.2%); the trailing year was depressed.

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• These shares are no longer priced on Huntsman alone: each one is set to convert into 0.5476 Olin shares under an agreed all-stock merger of equals, with both shareholder votes scheduled for August 25, 2026.

• The business underneath that ratio is at a trough: March-quarter revenue of $1,420 million produced a $53 million net loss and $73 million of adjusted EBITDA, net debt leverage reached 6.1 times, and all three major rating agencies cut the credit.

• Second-quarter results arrive after the close on July 30, 2026, against management guidance for adjusted EBITDA of $100 million to $130 million.

Bull Case

The case for owning Huntsman today is largely a case for owning a slice of something bigger. Olin and Huntsman agreed an all-stock merger of equals in which each Huntsman share converts into 0.5476 Olin shares, leaving Huntsman holders roughly 45.5% of a business to be renamed OlinHuntsman Corporation and headquartered in The Woodlands, Texas. The two companies describe the result as an integrated North American chemicals platform, and the fit is not cosmetic: Olin's chlor-alkali output sits directly upstream of the raw material chain Huntsman's polyurethanes business buys from third parties today.

The numbers attached to that fit are the reason to care. The companies identified more than $400 million of total cost synergies and integration benefits, of which more than $300 million is cost synergies from purchasing, raw material integration, operational optimisation and overhead. Set against a Huntsman that generated $73 million of adjusted EBITDA in the March quarter, a figure of that size is not a rounding item bolted onto a press release. It is the entire thesis.

The self-help was working before any of that was announced. Huntsman targeted $100 million of annualised savings and has realised roughly $110 million, with about $45 million of further year-over-year benefit expected to land during 2026. Advanced Materials, the smallest division, grew adjusted EBITDA 25% to $45 million in the quarter while the two larger ones went backwards. It is also the division least exposed to the construction and durable-goods cycle that is currently pinning the rest of the portfolio.

There are early signs the cycle itself is turning. Management guided second-quarter adjusted EBITDA to a range of $100 million to $130 million against $73 million in the first quarter, and Polyurethanes volumes rose 4% year over year on demand in the Americas and Europe. A sequential step of that size in commodity chemicals is usually volume and pricing moving together rather than one of them alone.

And the shares change hands below the accounting value of the assets. On book value and its convergence, the price sits at about 0.88 times where those methods land. For a producer whose plants take years and permits to replicate, an equity trading under the carried value of that plant is the sort of thing a strategic counterparty eventually notices. One just did.

Bear Case

Take the merger away and what is left is a chemicals company in the worst stretch of its cycle carrying too much debt. Huntsman lost $53 million in the March quarter on $1,420 million of revenue, used $53 million of cash in operations and burned $91 million of free cash flow. Trailing operating income across the last twelve months is negative, a loss margin of roughly 1.5% of revenue. The company's own leverage measure climbed to 6.1 times net debt to adjusted earnings from 4.0 times a year earlier, liquidity fell to $867 million from $1.29 billion, and all three major rating agencies downgraded the credit.

The merger does not fix that quickly, and it introduces problems of its own. Because it is all stock, Huntsman holders are exchanging one trough asset for a share of a combined trough asset. The exchange ratio was struck against the thirty-day volume-weighted average of both stocks through the close on June 12, 2026, which fixed the relative terms at a moment when both companies were depressed. And the synergies, all $400 million of them, are expected to be fully realised only by 2031. That is a long stretch to hold a leveraged commodity producer for a benefit arriving at the far end of it.

There is also the plain risk that nothing completes. Both shareholder bases vote at virtual special meetings on August 25, 2026, the registration statement became effective only on July 13, 2026, and completion is targeted for the first half of 2027 subject to regulatory clearance. Until then, Huntsman's quote is substantially Olin's quote multiplied by a fixed ratio and discounted for deal risk, which is a different exposure from the one a chemicals investor believes they are buying. If the agreement falls over, the standalone balance sheet is what remains.

On the standalone economics, what the quote asks for looks modest and is still not obviously safe. The price implies operating profit compounding at about 1.6% a year, and it asks that of a through-cycle earnings base rather than of the trailing loss. That assumption does the heavy lifting: it credits the company with the roughly 6.2% operating margin its own record supports, at a moment when the last twelve months delivered a loss. The bet is not really about growth. It is about reversion, and reversion in commodity chemicals depends on other producers' capacity decisions rather than on anything Huntsman controls.

The dividend already told this story. The quarterly payout now stands at $0.0875 a share, reduced from its earlier level, and the cash it consumes still has to come from a business producing $141 million of trailing free cash flow against $2,056 million of gross debt.

The valuation frames split badly, and one of them is unusable. The single earnings-power method puts the price at about 2.59 times its estimate, and the forward-looking methods at about 1.89 times, both reflecting a trough year fed in as the input. A sector revenue multiple applied to a company earning nothing produces an answer several times the quote, which is an artefact of arithmetic rather than a finding about the business.

Valuation

The first thing to understand about this quote is that it is only partly Huntsman's. Since mid June each share has carried the right to receive 0.5476 Olin shares under an agreed all-stock merger of equals, so the $12.90 price now tracks Olin's, adjusted for whatever odds the market assigns to completion. What follows describes the business sitting underneath that ratio, which is what a holder ends up owning in either outcome.

On its own economics the shares carry about 11.4 times mid-cycle operating income, and the price implies operating profit compounding at roughly 1.6% a year. Mid-cycle is the word doing the work. Trailing operating income is negative, a loss margin of around 1.5% of revenue, so the calculation runs on the through-cycle profitability the company's own record supports, a margin near 6.2%, rather than on the trough it currently occupies. Read the implied figure as a statement about reversion, not about expansion.

Where the various approaches land is unusually informative here. Book value roughly brackets the quote: the price sits at about 0.88 times where those methods come out, meaning the market pays slightly less than the carried accounting value of the plants. The forward-looking methods put the price at about 1.89 times their estimate, and the single earnings-power method at about 2.59 times, both of which follow mechanically from a loss-making year being the input. The revenue-multiple comparison is the one to set aside entirely: applying a sector average to a company with no earnings returns a figure several times the quote, and that says more about the method than about Huntsman.

The peer set is a genuine one for once. LyondellBasell, Dow, Olin, Celanese and Eastman are real comparables for the polyurethanes and performance products lines, and Avient, Celanese, Eastman, Chemours and Rogers for advanced materials. What the cohort has in common right now is that the entire North American commodity chemicals complex is operating below mid-cycle, which is precisely the condition that makes consolidation attractive to the participants and makes any single company's trough multiple hard to interpret in isolation.

Solvency decides how much time there is. Cash was $369 million against total debt of $2,056 million at the end of March, leaving net debt of $1,687 million. Measured against through-cycle operating income, that is roughly 4.75 times over, which is manageable in a normal year. Measured the way the rating agencies measure it, net leverage reached 6.1 times and all three of them downgraded, with liquidity down to $867 million. The share count has come down about 5.3% a year over the past four years, which is part of the explanation for where the balance sheet now sits: capital returned before the downturn is capital not available during it.

What governs the outcome from here is the calendar more than the cycle. Approve the deal on August 25 and clear the regulators, and a Huntsman holder becomes the owner of roughly 45.5% of a larger company with more than $400 million of identified synergies to pursue. Fail to, and the trough balance sheet described above is the entirety of the position.

Catalysts

Three dates and one ratio shape the next six months.

Huntsman releases second-quarter results after the market close on July 30, 2026, with the call the following morning. Management guided total adjusted EBITDA to a range of $100 million to $130 million against $73 million in the first quarter. The size of that step is the cleanest test available of whether the increases Huntsman pushed through after feedstock costs spiked in March have actually held. Polyurethanes volumes were up 4% year over year in the March quarter; volume and pricing together would confirm a real turn, volume on its own would not.

The merger vote is August 25, 2026, when both shareholder bases meet in virtual special meetings. The registration statement became effective on July 13, 2026, which cleared the procedural path to those meetings. Approval hands the question to regulators, with completion targeted for the first half of 2027.

The figure worth tracking between those dates is leverage. Net debt to adjusted earnings reached 6.1 times in the March quarter, up from 4.0 times a year earlier, with liquidity at $867 million. A cyclical recovery pulls that down with no deal required. A second soft quarter does the reverse, and does it directly into a shareholder vote.

Peer Cohorts (Per Segment, With Filing Citations)

Polyurethanes (reported)

• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals such as styrene monomer and acetyls. • Advanced Polymer Solutions ("APS"). Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered…
• FY2025 10-K: …production of PP and propylene oxide and derivatives of those products, and we regularly purchase propylene from third parties because our internal needs exceed our internal production. In addition to purchases of propylene, we purchase ethylene for resale, when necessary, to satisfy customer demand above our own…
• DOW (Dow Inc.)
• FY2025 10-K: Acrylic Emulsion Polymers, WALOCEL ™ Cellulose Ethers Aniline, benzene, carbon monoxide, caustic soda, cell effluent, cellulose, chlorine, electric power, ethylene, hydrogen peroxide, propylene Arkema, Ashland, BASF, Covestro, Eastman, Huntsman, INEOS, LyondellBasell, Wanhua Joint Ventures This segment includes a…
• FY2025 10-K: …for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets within the Industrial Intermediates & Infrastructure segment. In the third quarter of 2024, the Company recorded additional pretax restructuring charges of $ 7 million for asset write-downs and write-offs related to the…
• OLN (Olin Corporation)
• FY2025 10-K: …the Chlor Alkali Products and Vinyls segment to generate caustic soda production and sales. Chlorine and caustic soda used in our Epoxy segment are transferred at cost from the Chlor Alkali Products and Vinyls segment. The following table lists the principal products and services of our Epoxy segment: Products &…
• FY2025 10-K: …integrated producer economics. Methanol is primarily sourced from large domestic and international producers. The high-volume nature of the chlor alkali industry places emphasis on cost management, and we believe that our scale, integration and raw material positions make us one of the low-cost producers in the…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …and withstanding deformation. Nylon compounds are used in a range of applications including automotive, consumer, electrical, electronic and industrial. These value-added applications in diverse end uses support the business' global growth objectives. POM, PBT and LFRT are used in a broad range of…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• FY2025 10-K: …of high-purity wood pulps for which the Company has dependable sources of supply. Principal Products Product Description Principal Competitors Key Raw Materials End-Use Applications Acetate Tow Estron ™ cellulose acetate tow Celanese Corporation Cerdia International Daicel Corporation Jinan Acetate Chemical wood pulp…

Performance Products (reported)

• DOW (Dow Inc.)
• FY2025 10-K: …Consumer Solutions consists of two businesses: Performance Silicones & Specialty Materials and Silicone Feedstocks & Intermediates. The Performance Silicones & Specialty Materials business delivers a comprehensive portfolio of performance-enhancing products to meet the diverse needs of customers in high-growth…
• FY2025 10-K: …in paper packaging for food and beverage markets, as well as adding new silicone intermediates and downstream product capabilities across multiple end-markets such as infrastructure; consumer and electronics; personal care; and mobility. Investments in innovation for growth are focused on addressing market needs such…
• WLK (Westlake Corporation)
• FY2025 10-K: …reducing waste at our facilities, incorporating more recycled content into our products, seeking to incorporate renewable and bio-based materials, and producing products that support greater efficiency and durability. Housing and Infrastructure Products Business Our HIP segment is primarily comprised of residential…
• FY2025 10-K: …outdoor living products include Zuri ® Premium Decking. PVC Pipe. We manufacture and sell PVC pipe ranging in sizes from ½ inch to 36 inches in diameter, in gasketed, solvent welded, and restrained joint configurations. Our pipe products are used in residential water and sewer applications; municipal potable water…
• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals such as styrene monomer and acetyls. • Advanced Polymer Solutions ("APS"). Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered…
• FY2025 10-K: …and Derivatives ("I&D") segment, new octane capacity pressured oxyfuels and related products margins through most of the summer driving season. Our APS segment delivered meaningful gains through margin improvement, portfolio optimization and increased business win rates. In 2025, we agreed to sell certain European…
• CE (CELANESE CORPORATION)
• FY2025 10-K: …Contents allows us to create a demand pull for our solutions. This business segment also includes 17 strategic affiliates that complement our global reach, improve our ability to capture growth opportunities in emerging economies. • Key Products Elastomers. Vamac ® EAE, our elastomer brand, is primarily used in…
• FY2025 10-K: …or long-lived assets. Failure to develop new products, product applications, and production technologies may harm our competitive position. Our operating results depend significantly on the development of commercially viable new products, product grades and applications, as well as improving process technologies. If…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …and assess performance of the Company. The CODM evaluates segment operating performance, and makes resource allocation and performance evaluation decisions, based on Adjusted EBIT, defined as the GAAP measure earnings before interest and taxes ("EBIT"), adjusted for non-core, unusual, or non-recurring items. These…
• FY2025 10-K: …products and applications to help facilitate AM segment growth and leverage its manufacturing capacity. The AM segment is positioned to benefit from Eastman polyesters and acetyl streams sustainability innovations by leveraging molecular recycling technologies to enable various waste plastics to be recycled into…
• OLN (Olin Corporation)
• FY2025 10-K: 0 days from date of invoice. Our contracts do not typically have a significant financing component. Right to payment is determined at the point in time in which control has transferred to the customer. A performance obligation is a promise in a contract to transfer a distinct good to the customer. At contract…
• FY2025 10-K: …These actions include: • Protecting our employees and communities through our industry-leading occupational and process safety programs • Proudly strengthening United States defense, international defense, law enforcement, and conservation through our Winchester ammunition brand • Significantly reducing our…
• CC (Chemours Co)
• FY2025 10-K: …the cyclicality of key end markets, such as industrial, chemical processing, consumer goods, and transportation, and is expected to grow in line with GDP. However, with growing demand for cleaner and faster technologies, demand for products in the performance solutions portfolio is expected to grow at a rate faster…
• FY2025 10-K: …temperature stability, and unique di-electric properties. Our Advanced Performance Materials segment has a diversified offering of products that includes various specialty product solutions, membranes, industrial resins, and coatings across our Teflon TM , Viton TM , Krytox TM , and Nafion TM brand portfolios. These…
• AVNT (AVIENT CORPORATION)
• FY2025 10-K: …or reductions or significant facility operating problems. Other external factors beyond our control, including, but not limited to, trade barriers due to geopolitical tensions, can also cause fluctuations in raw materials prices, which could negatively impact demand for our products and cause volatility in our…
• FY2025 10-K: …are primarily customer receivables, inventories, net property, plant and equipment, intangible assets and goodwill. Corporate assets and liabilities primarily include cash, debt, pension and other employee benefits, environmental liabilities, and other unallocated corporate assets and liabilities. The accounting…

Advanced Materials (reported)

• AVNT (AVIENT CORPORATION)
• FY2025 10-K: NT CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1 - DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered…
• FY2025 10-K: …should be reduced based on consideration of all available evidence, both positive and negative, using a "more likely than not" standard. See Note 11, Income Taxes , for additional detail. Note 2 - GOODWILL AND INTANGIBLE ASSETS Changes in the carrying amount of goodwill by segment were as follows: (In millions)…
• CE (CELANESE CORPORATION)
• FY2025 10-K: Asia and consist of 51 global production facilities and an additional 20 strategic affiliate production facilities. As of December 31, 2025, we employed 11,434 people worldwide. Business Segment Overview We operate principally through two business segments: Engineered Materials and the Acetyl Chain. See Business…
• FY2025 10-K: …Engineered Materials business segment. The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses.…
• EMN (EASTMAN CHEMICAL CO)
• FY2025 10-K: …products and applications to help facilitate AM segment growth and leverage its manufacturing capacity. The AM segment is positioned to benefit from Eastman polyesters and acetyl streams sustainability innovations by leveraging molecular recycling technologies to enable various waste plastics to be recycled into…
• FY2025 10-K: …polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma; and consumables end-markets. Key technology platforms for this segment include cellulosic biopolymers, copolyesters, and PVB and…
• CC (Chemours Co)
• FY2025 10-K: …judgments surrounding general market and economic conditions, short- and long-term revenue growth rates, gross margins, and prospective financial information surrounding future cash flows of the reporting units. Projections are based on internal forecasts of future business performance and are based on growth…
• FY2025 10-K: …by product line and markets served. Our Advanced Performance Materials segment maintains a fleet of railcars, tank trucks, containers, and totes to deliver our products and support our supply chain needs. For the portion of the fleet that is leased, the related lease terms are usually staggered, which provides us…
• ROG (Rogers Corporation)
• FY2025 10-K: …following strategic operating segments: AES and EMS. Our remaining operations, which represent our non-core businesses, are reported in the Other operating segment. We believe this structure aligns our external reporting presentation with how we currently manage and view our business internally. Our CODM is the…
• FY2025 10-K: …industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets. We believe these materials have characteristics that offer performance and other functional advantages in many…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Olin and Huntsman joint announcement, June 16, 2026, and joint proxy statement, July 2026 · Huntsman first quarter 2026 results and investor presentation, May 2026 · Huntsman first quarter 2026 results, May 2026, and earnings-call schedule, June 30, 2026 · Olin and Huntsman joint announcement, June 16, 2026 · Huntsman first quarter 2026 results, May 2026 · Huntsman first quarter 2026 investor presentation, May 2026 · Olin and Huntsman joint proxy statement, July 2026 · Huntsman second quarter 2026 dividend declaration, May 2026 · Huntsman earnings-call schedule, June 30, 2026 · Huntsman first quarter 2026 earnings call, May 2026 · Olin and Huntsman securities filing, July 2026